Projected distribution of global available new active substances by disease type between 1996 and 2020*

Projection of new active substance distribution by disease 1996-2020 This statistic shows the projected distribution of new active substances available between 1996 and 2020, sorted by disease group. It is estimated that some 24 percent of new active substances will be available for treating orphan diseases during that period.
Show more
Loading statistic...
Percentage of new active substances available
Infection14%
Oncology13%
Neurology8%
Cardiovascular 7%
Blood & related disorders5%
Diabetes6%
Orphan24%
Others23%
Percentage of new active substances available
Infection14%
Oncology13%
Neurology8%
Cardiovascular 7%
Blood & related disorders5%
Diabetes6%
Orphan24%
Others23%
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the projected distribution of new active substances available between 1996 and 2020, sorted by disease group. It is estimated that some 24 percent of new active substances will be available for treating orphan diseases during that period.
Show more
Release date
November 2015
Region
Worldwide
Survey time period
1996 to 2015
Supplementary notes
Note: Disease categories based on therapy areas and expected launches 2016-20. Orphan drugs are those to treat small populations with rare diseases, and are defined separately by U.S. FDA and the European Medicines Agency (EMA). Any medicine with an orphan designation for an approved use within the first year after global launch are categorized as Orphan. Half of designated orphan indications are granted more than a year after original approval.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Global pharmaceutical industry"

  • Overview
The most important statistics
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
  • Outlook
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.